SNC
PFE icon

Stifel Nicolaus & Co’s Pfizer PFE Stock Holding History

Stifel Nicolaus & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$42.5M Buy
1,557,990
+45,631
+3% +$1.24M 0.7% 19
2013
Q2 		$40.2M Buy
+1,512,359
New +$41.8M 0.73% 20

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Stifel Nicolaus & Co's PFE Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its Pfizer (PFE) stake by 3% in Q3 2013, buying an estimated $1.24M and bringing the position to 1,557,990 shares worth $42.5M. The position accounts for 0.7% of the portfolio, ranked #19.

Stifel Nicolaus & Co first reported a position in PFE in Q2 2013 and has held it in 2 quarters since. 1,606 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Stifel Nicolaus & Co held 1,557,990 shares of Pfizer worth $42.5M as of Q3 2013.
  • Stifel Nicolaus & Co bought 45,631 Pfizer shares in Q3 2013, an estimated $1.24M.
  • Pfizer made up 0.7% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #19 holding.
  • Stifel Nicolaus & Co first reported a position in Pfizer in Q2 2013 and has held it in 2 quarters since.
  • 1,606 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.